Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (TREM-1) TREM-like transcript 1 (TLT-1) for treatment of cardiovascular diseases

Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (TREM-1) TREM-like transcript 1 (TLT-1) for treatment of cardiovascular diseases

US Patent 9657081 · Granted May 23, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for treating septic shock2025
Method for treating septic shock2025
B cell depleting agent for the treatment of atherosclerosis2024
Mesenchymal stem cells obtained from Wharton's jelly for the treatment of sepsis2024
Mesenchymal stem cells obtained from Wharton's jelly for the treatment of sepsis2024
Methods and kits for predicting the risk of having a cardiovascular disease or e2021
Methods and kits for predicting the risk of having a cardiovascular disease or e2021
Methods and kits for predicting the risk of having a cardiovascular disease or e2021
Methods and kits for predicting the risk of having a cardiovascular disease or e2021
Therapeutic TREM-1 peptides2020
Agent capable of depleting CD8 T cells for the treatment of myocardial infarctio2020
Inhibiting peptides derived from TREM-like transcript 1 (TLT-1) and uses thereof2017